Epidarex raises L47.5 million for first fund

Epidarex Capital (formerly Rock Spring Ventures) raised more than L47.5 million ($80.3 million) for a fund focused on early stage life science and health technology companies in the U.K. Investors included Eli Lilly and Co. (NYSE:LLY); King's College London; the European Investment Fund (EIF); Scottish Enterprise and Strathclyde Pension Fund. The firm said it is Lilly's first investment in a U.K. venture fund. ...